Premenstrual Syndrome and Premenstrual Dysphoric Disorder

被引:6
|
作者
Hofmeister, Sabrina [1 ]
Bodden, Seth [1 ]
机构
[1] Med Coll Wisconsin, Dept Family & Community Med, Milwaukee, WI 53226 USA
关键词
PREVALENCE; THERAPY; MANAGEMENT; ESTRADIOL;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Premenstrual disorders affect up to 12% of women. The subspecialties of psychiatry and gynecology have developed overlapping but distinct diagnoses that qualify as a premenstrual disorder; these include premenstrual syndrome and premenstrual dysphoric disorder. These conditions encompass psychological and physical symptoms that cause significant impairment during the luteal phase of the menstrual cycle, but resolve shortly after menstruation. Patient directed prospective recording of symptoms is helpful to establish the cyclical nature of symptoms that differentiate premenstrual syndrome and premenstrual dysphoric disorder from other psychiatric and physical disorders. Physicians should tailor therapy to achieve the greatest functional improvement possible for their patients. Select serotonergic antidepressants are first-line treatments. They can be used continuously or only during the luteal phase. Oral contraceptives and calcium supplements may also be used. There is insufficient evidence to recommend treatment with vitamin D, herbal remedies, or acupuncture, but there are data to suggest benefit from cognitive behavior therapy. Copyright (C) 2016 American Academy of Family Physicians.
引用
收藏
页码:236 / 240
页数:5
相关论文
共 50 条
  • [41] Premenstrual dysphoric disorder
    Sander, Bethany J.
    Gordon, Jennifer L.
    Brennand, Erin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (42) : E1384 - E1384
  • [42] Premenstrual dysphoric disorder
    Strelow, Brittany
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (05): : 45 - 46
  • [43] Premenstrual Dysphoric Disorder
    di Scalea, Teresa Lanza
    Pearlstein, Teri
    MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (04) : 613 - +
  • [44] Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: A clinical primer for practitioners
    Johnson, SR
    OBSTETRICS AND GYNECOLOGY, 2004, 104 (04): : 845 - 859
  • [45] Impact of premenstrual syndrome and premenstrual dysphoric disorder on maternal antenatal depression
    Ihara, Nozomi
    Sato, Yoko
    Ikeda, Subaru
    Matsufuji, Hiromi
    Kikuchi, Kimiyo
    Suetsugu, Yoshiko
    Hikita, Naoko
    Morokuma, Seiichi
    PLOS ONE, 2024, 19 (12):
  • [46] Premenstrual Dysphoric Disorder and Severe Premenstrual Syndrome in AdolescentsDiagnosis and Pharmacological Treatment
    Andrea J. Rapkin
    Judith A. Mikacich
    Pediatric Drugs, 2013, 15 : 191 - 202
  • [47] A symptom diary to assess severe premenstrual syndrome and premenstrual dysphoric disorder
    Janda, Carolyn
    Kues, Johanna N.
    Andersson, Gerhard
    Kleinstauber, Maria
    Weise, Cornelia
    WOMEN & HEALTH, 2017, 57 (07) : 837 - 854
  • [48] Premenstrual dysphoric disorder
    Grady-Weliky, TA
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05): : 433 - 438
  • [49] Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
    Jespersen, Cecilie
    Lauritsen, Mette Petri
    Frokjaer, Vibe G.
    Schroll, Jeppe B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (08):
  • [50] Premenstrual Dysphoric Disorder
    di Scalea, Teresa Lanza
    Pearlstein, Teri
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2017, 40 (02) : 201 - +